SCHEMBL6558933

SCHEMBL6558933

O=C(NC(CO)Cc1cc(F)cc(F)c1)OCc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTRB1 P17538 2/20 0.60
CYP3A4 P08684 7/20 0.48
ALDH1A1 P00352 3/20 0.48
TSHR P16473 3/20 0.48
CYP1A2 P05177 2/20 0.48
CYP2D6 P10635 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP2C19 P33261 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
BACE1 P56817 1/20 0.47
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
KMT2A Q03164 1/20 0.46
MAPK1 P28482 1/20 0.46
SYK P43405 1/20 0.46
TACR1 P25103 2/20 0.45
PIN1 Q13526 1/20 0.45
MGLL Q99685 1/20 0.44
CTSL P07711 1/20 0.44
CTSB P07858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5929971 1.00 CTRB1 (0.60) CTRB1CYP3A4ALDH1A1TSHRCYP1A2
SCHEMBL7460347 0.91 CTRB1 (0.59) CTRB1CYP3A4ALDH1A1TSHRCYP1A2
SCHEMBL7460349 0.91 CTRB1 (0.59) CTRB1CYP3A4ALDH1A1TSHRCYP1A2
SCHEMBL2435512 0.88 CTRB1 (0.76) CTRB1CYP3A4ALDH1A1TSHRCYP1A2
SCHEMBL1051352 0.88 CTRB1 (0.76) CTRB1CYP3A4ALDH1A1TSHRCYP1A2
SCHEMBL2482903 0.88 CTRB1 (0.76) CTRB1CYP3A4ALDH1A1TSHRCYP1A2
Carbamic Acid SCHEMBL8426357 0.84 CTRB1 (0.70) CTRB1CYP3A4ALDH1A1TSHRCYP1A2
Carbamic Acid SCHEMBL8426387 0.84 CTRB1 (0.70) CTRB1CYP3A4ALDH1A1TSHRCYP1A2
SCHEMBL4829896 0.83 CTRB1 (0.68) CTRB1ALDH1A1CYP1A2SMN1; SMN2NPC1
SCHEMBL3303033 0.83 ITGB3 (0.56) CTRB1ALDH1A1TACR1CTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1392645-A2 AZA HYDROXYLATED ETHYL AMINE COMPOUNDS Elan Pharmaceuticals, Inc. (US) 2004-03-03 EP disclosed
EP-1392315-A1 METHODS OF TREATING ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2004-03-03 EP disclosed
WO-2002100410-A1 METHODS OF TREATING ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-12-19 WO disclosed
WO-2002094768-A2 AZA HYDROXYLATED ETHYL AMINE COMPOUNDS ELAN PHARMACEUTICALS, INC. (US) 2002-11-28 WO disclosed